Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.041 | 0.8 |